Latest data on Bayer's Essure show more patients had device removed: FDA

FDA has updated its information about the removal of Bayer's Essure birth control devices with the latest results of postmarket studies.
One of the studies found the rate of Essure device removal for all subjects for any reason rose from 15.5% at seven years of follow-up to 17.8% at eight years of follow-up. The second study put the rate of device removal after 22 months at 10%.